Clinical Trial Update: A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating Becotatug Vedotin combined with Pucotenlimab for EGFR-positive advanced penile cancer, currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Drugs mentioned

• Becotatug Vedotin
• Pucotenlimab

Snippet

Sponsor: Fudan University | Conditions: Penile Cancer | Phase 2 | Status: NOT_YET_RECRUITING